Gainers
- Mersana Therapeutics MRSN shares rose 22.7% to $2.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $331.2 million. As per the news, the Q3 earnings report came out today.
- Kairos Pharma KAPA stock rose 19.74% to $2.46. The market value of their outstanding shares is at $31.5 million.
- Calidi Biotherapeutics CLDI shares increased by 18.48% to $2.5. The market value of their outstanding shares is at $29.1 million. The company's, Q3 earnings came out yesterday.
- Natera NTRA shares rose 16.66% to $157.64. The company's market cap stands at $19.4 billion. As per the news, the Q3 earnings report came out yesterday.
- Ensysce Biosciences ENSC stock increased by 15.62% to $0.78. The market value of their outstanding shares is at $11.6 million. The company's, Q3 earnings came out yesterday.
- Lexeo Therapeutics LXEO stock increased by 12.61% to $8.66. The company's market cap stands at $286.3 million. The company's, Q3 earnings came out today.
Losers
- Syros Pharmaceuticals SYRS shares decreased by 85.6% to $0.39 during Wednesday's pre-market session. The market value of their outstanding shares is at $10.5 million.
- GlucoTrack GCTK stock decreased by 72.24% to $0.44. The market value of their outstanding shares is at $2.5 million.
- Psyence Biomedical PBM stock fell 23.4% to $0.05. The company's market cap stands at $2.9 million.
- CERo Therapeutics Hldgs CERO shares declined by 20.03% to $0.21. The market value of their outstanding shares is at $32.1 million.
- Geovax Labs GOVX shares declined by 20.0% to $2.6. The company's market cap stands at $22.1 million. As per the press release, Q3 earnings came out yesterday.
- Virpax Pharmaceuticals VRPX shares fell 17.6% to $0.51. The market value of their outstanding shares is at $2.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in